Originally published May 11, 2023 2:00 pm PDT
The World Health Organization (WHO) has announced that monkeypox is no longer considered a global public health emergency due to a significant decrease in cases in recent months.
In a media briefing held on Thursday, WHO Director-General Tedros Adhanom Ghebreyesus revealed that the organization’s emergency committee had advised him on Wednesday that the monkeypox outbreak “no longer represents a public health emergency of international concern.”
“I have accepted that advice and am pleased to declare that monkeypox is no longer a global health emergency,” Tedros said.
The WHO announcement comes after American Faith’s consistent coverage of the apparent outbreak.
We reported, for example, how a group linked to The World Economic Forum (WEF) had, over a year before the virus’ emergence, predicted the monkeypox outbreak nearly to the day.
We also reported the following information on the monkeypox vaccine side effects:
- The FDA package insert for Bavarian Nordic’s monkeypox vaccine states that heart problems of “special interest” occur in 1 in 75 vaccine recipients who have not already been vaccinated against smallpox, but also in 1 in 48 vaccine recipients who have already been vaccinated against smallpox. The insert indicates Bavarian Nordic added ‘tromethamine,’ a drug given to treat heart attacks, to the vaccine.
- The CDC has reported how one in four women (25%) who became pregnant after being injected with Bavarian Nordic’s monkeypox vaccine suffered a “spontaneous abortion.”
- The monkeypox vaccine insert also says the vaccine “has not been evaluated” for “[i]mpairment of male fertility.”
- It is not known whether Bavarian Nordic’s monkeypox vaccine is excreted in human breastmilk: “Data are not available to assess the effects of JYNNEOS in the breastfed infant or on milk production/excretion,” the FDA insert reads.
- The insert also warns that the monkeypox vaccine “has not been evaluated for carcinogenic or mutagenic potential,” meaning it is unknown whether the vaccine causes cancer or genetic mutations in humans.
- MIT has reported that Bavarian Nordic’s vice president of clinical strategy, Heinz Weidenthaler, admitted the effectiveness of the company’s monkeypox vaccine has not yet been tested: “[W]e’ve simply had no opportunity to test this in humans,” said Weidenthaler.
- There are no long-term studies evaluating how the monkeypox vaccine will interact with the COVID-19 vaccine, itself already linked to heart disease (here, here, here, here).
- The WHO has admitted that the monkeypox vaccine is “not 100% effective” against the virus.
Recognizing patterns in geopolitical developments regarding monkeypox that were similar to those which took place before, during, and after the COVID-19 outbreak, American Faith made the editorial decision early on to cover monkeypox-related news at length and in depth.
This decision was made despite and as a result of no other news outlet doing so.
See some of our reports below:
